XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
84 hedge funds and large institutions have $639M invested in Acceleron Pharma in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 28 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
11% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 28
37% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 19
Holders
84
Holding in Top 10
5
Calls
$4.6M
Puts
$2.01M
Top Buyers
| 1 | +$10.3M | |
| 2 | +$6.86M | |
| 3 | +$6.05M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$4.38M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$4.15M |
Top Sellers
| 1 | -$10.2M | |
| 2 | -$9.61M | |
| 3 | -$5.84M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$3.41M |
| 5 |
IHM
Iguana Healthcare Management
New York
|
-$2.57M |